期刊
MOLECULAR AND CELLULAR BIOLOGY
卷 35, 期 5, 页码 831-846出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.01109-14
关键词
-
资金
- National Institutes of Health (NIH) [R01HL070070, R01DK092065, U01HL70525]
- American Diabetes Association
- JDRF [10-2009-672]
- NIH [K99R00 HL111322, T32 HL007576]
- German Research Foundation (DFG)
- Spanish Ministry of Education and Science
- AHA, Western Affiliates
- Grants-in-Aid for Scientific Research [24591094] Funding Source: KAKEN
Sustained Akt activation induces cardiac hypertrophy (LVH), which may lead to heart failure. This study tested the hypothesis that Akt activation contributes to mitochondrial dysfunction in pathological LVH. Akt activation induced LVH and progressive repression of mitochondrial fatty acid oxidation (FAO) pathways. Preventing LVH by inhibiting mTOR failed to prevent the decline in mitochondrial function, but glucose utilization was maintained. Akt activation represses expression of mitochondrial regulatory, FAO, and oxidative phosphorylation genes in vivo that correlate with the duration of Akt activation in part by reducing FOXO-mediated transcriptional activation of mitochondrion-targeted nuclear genes in concert with reduced signaling via peroxisome proliferator-activated receptor alpha (PPAR alpha)/PGC-1 alpha and other transcriptional regulators. In cultured myocytes, Akt activation disrupted mitochondrial bioenergetics, which could be partially reversed by maintaining nuclear FOXO but not by increasing PGC-1 alpha. Thus, although short-term Akt activation may be cardioprotective during ischemia by reducing mitochondrial metabolism and increasing glycolysis, long-term Akt activation in the adult heart contributes to pathological LVH in part by reducing mitochondrial oxidative capacity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据